Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New antipsychotic drugs from HMR

April 5, 1996

Meiji claims improved antipsychotic agents

April 5, 1996

Warner-Lambert discloses ACAT inhibitors

April 5, 1996

BMS claims beta3 agonists in patent literature

April 5, 1996

ACAT inhibitors claimed by DuPont Merck

April 5, 1996

Kyowa Hakko discloses UCF76-B

April 5, 1996

New angiogenesis inhibitors from ADIR

April 5, 1996

Merck & Co. reports farnesyl transferase inhibitors

April 5, 1996

Antineoplastic fusion proteins from Bristol-Myers Squibb

April 5, 1996

MAbs for treatment of melanoma

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 16, 2025.
Illimis $42M series B to spur study of Aβ-clearing fusion protein
BioWorld
Illimis Therapeutics Inc. raised ₩58 billion (US$42 million) in a series B financing round. The funds will support development of ILM-01, its lead bispecific...
Proteomics finds surprise commonalities as well as differences in neurodegenerative diseases
BioWorld
The switch will be flicked today to make the world’s largest dementia-related proteomics dataset freely available to researchers, at the same time as members of...
Circode applies circRNA to heart disease drug R&D, in vivo CAR T
BioWorld
Shanghai Circode Biomed Co. Ltd. is set to begin clinical trials of HM-2002, a circular RNA (circRNA)-based drug for ischemic heart disease, having gained IND...